ANTIBACTERIAL SUBSTANCE PRODUCED BY A SOIL BACTERIA ISOLATED FROM RHIZOSPHERE OF ZINGIBER OFFICINALE
Keywords:Antibacterial substance, Rhizosphere, Burkholderia sp, 16S rRNA
Objective: In our previous study, we have found many isolates of bacteria from Zingiber officinale rhizosphere in Magelang, Central Java, Indonesia. J4, one of the isolates, has been found to contain metabolites which have antibacterial activity. The active chemical compound was unidentified. This study aims to identify the molecular formula of the active compound which has potential antibacterial activity.
Methods: Identification of selected bacteria (J4 isolate) was based on the 16S rRNA gene sequence. Extraction of J4 isolate culture broth was carried out using ethyl acetate and followed by fractionation with hexane, chloroform-methanol (7:3), and methanol. The fraction which has antibacterial activity analyzed using IR Spectroscopy and LC-TOF-MS.
Results: BLAST analysis result of the 16S rRNA sequence showed that J4 isolate is Burkholderia sp with 99% similarity. According to the IR spectroscopy examination of the active fraction, there were OH, CH, and carbonyl stretching. LC-TOF-MS analysis showed 5 molecular formulas with m/z of 253, 274, 387 (two formulas), and 404 in the active fraction, but there was one formula with no OH groups.
Conclusion: J4 isolate is a Burkholderia sp. The molecular formula for the antibacterial substance that might be produced by J4 isolate is C6H12N12, C21H29N3O5, C21H26N2O5, C17H22N8O3, and/or C15H35N3O.
2. Berdy J. Bioactive microbial metabolites. J Antibiot 2005;58:1-26.
3. Raja A, Prabakarana P. Actinomycetes and drug-an overview. Am J Drug Discovery Dev 2011;1:75-84.
4. Hidayati DN, Lestari Y, Marwoto B. Characterization of Micromonospora spp. with activity against beta-lactam antibiotic-resistant Escherichia coli ATCC 35218. Microbiol Indones 2013;7:85-93.
5. Genilloud O, Gonzales I, Salazar O, Martin J, Tormo JR, Vincente F. Current approaches to exploit actinomycetes as a source of novel natural products. J Ind Microbiol Biotechnol 2011;38:375-89.
6. Pham JV, Yilma MA, Feliz A, Majid MT, Maffetone N, Walker JR, et al. A review of the microbial production of bioactive natural products and biologics. Front Microbiol 2019;10:1-27.
7. Cremin PA, Zeng L. High-throughput analysis of natural product compound libraries by parallel LC-MS evaporative light scattering detection. Anal Chem 2002;74:5492-500.
8. Tormo JR, Garcia JB, DeAntonio M, Feliz J, Mira A, Diez MT, et al. A method for the selection of production media for actinomycetes strains based on their metabolite HPLC profiles. J Ind Microbiol Biotechnol 2003;30:582-8.
9. Hoffmann E, Stroobant V. Mass spectrometry: principles and applications. 3rd Edition. NewYork: John Wiley and Sons; 2013.
10. Nugrahani I, Mussadah MV. Development and validation analysis of acyclovir tablet content determination method using FTIR. Int J Appl Pharm 2016;8(Suppl 2):43-7.
11. Field LD, Sternhell S, Kalman JR. Organic structures from spectra. New York: John Wiley and Sons; 2008.
12. Smith BC. Fundamentals of fourier transform infrared spectroscopy. 2nd Edition. New York: CRC Press; 2011.
13. Anderson AS, Wellington EM. The taxonomy of streptomyces and related genera. Int J Syst Evol Microbiol 2001;51:797-814.
14. Egan S, Wiener P, Kallifidas D, Wellington EMH. Phylogeny of streptomyces species and evidence for horizontal transfer of entire and partial antibiotic gene clusters. Antonie Van Leeuwenhoek 2001;79:127-33.
15. Morningstar A, Gaze WH, Tolba S, Wellington EMH. Evolving gene clusters in soil bacteria. In: Prokaryotic Diversity. New York: Cambridge University Press; 2006.
16. Guo Y, Zheng W, Rong X, Huang Y. A multilocus phylogeny of the Streptomyces griseus 16S rRNA gene clade: use of multilocus sequence analysis for Streptomycetes systematics. Int J Syst Evol Microbiol 2008;58:149-59.
17. Alam MT, Merlo ME, Takano E, Breitling R. Genome-based phylogenetic analysis of Streptomyces and its relatives. Mol Phylogenet Evol 2010;54:763-72.
18. Yang B, Wang Y, Qian PY. Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis. BMC Bioinform 2016;17:1–8.
19. Devgan M. Structure prediction and in silico designing of drugs against kallikrein protein 12. Int J Curr Pharm Res 2017;9(Suppl 2):64-9.
20. Pawar S, Chaudhari A, Prabha R, Shukla R, Singh DP. Microbial pyrrolnitrin: natural metabolite with immense practical utility. Biomol 2019;9:1-26.
21. Schwab U, Abdullah LH, Perlmutt OS, Albert D, Davis CW, Arnold RR, et al. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus. Infect Immun 2014;82:4729–45.
22. Mullins AJ, Murray James AH, Bull MJ, Jenner M, Jones C, Webster G, et al. Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifaria. Nat Microbiol 2019;4:996–1005.
23. Cheng Z, Wu T. TLC bioautography: high throughput technique for screening of bioactive natural products. Comb Chem High Throughput Screen 2013;16:531–49.
24. Fahim M, Ibrahim M, Zahiruddin S, Parveen R, Khan W, Ahmad S, et al. TLC-bioautography identification and GC-MS analysis of antimicrobial and antioxidant active compounds in Musa paradisiaca L. fruit pulp essential oil. Phytochem Anal 2019;30:332–45.